Want to see RARE full AI Analyst Report?
Ultragenyx Pharmaceutical (RARE) Earnings Dates, Call Summary & Reports
Earnings Data
- Estimated Report Date
- Nov 03, 2026
- Period Ending
- 2026 (Q3)
- Consensus EPS Forecast
- -1.10
- Last Year’s EPS
- -1.81
After Close (Not Confirmed)
Same Quarter Last Year
Ultragenyx Pharmaceutical (RARE) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
RARE Q2 2026 Earnings Report
RARE Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for November 3, 2026, based on past reporting schedules.
RARE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Nov 03, 2026 | 2026 (Q3) | -1.10- | -1.81 | ― | ― | ― | ― |
| Aug 04, 2026 | 2026 (Q2) | -1.22-0.90 | -1.17 | 23.08% (+0.27) | ― | ||
| May 05, 2026 | 2026 (Q1) | -1.49-1.84 | -1.57 | -17.20% (-0.27) | ― | ||
| Feb 12, 2026 | 2025 (Q4) | -1.09-1.29 | -1.39 | 7.19% (+0.10) | ― | ||
| Nov 04, 2025 | 2025 (Q3) | -1.23-1.81 | -1.4 | -29.29% (-0.41) | ― | ||
| Aug 05, 2025 | 2025 (Q2) | -1.30-1.17 | -1.52 | 23.03% (+0.35) | |||
| May 06, 2025 | 2025 (Q1) | -1.60-1.57 | -2.03 | 22.66% (+0.46) | |||
| Feb 13, 2025 | 2024 (Q4) | -1.31-1.39 | -1.52 | 8.55% (+0.13) | |||
| Nov 05, 2024 | 2024 (Q3) | -1.48-1.40 | -2.23 | 37.22% (+0.83) | |||
| Aug 01, 2024 | 2024 (Q2) | -1.66-1.52 | -2.25 | 32.44% (+0.73) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
RARE Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Aug 04, 2026 | $25.81 | $24.93 | -3.41% |
| May 05, 2026 | $25.01 | $25.93 | +3.68% |
| Feb 12, 2026 | $23.50 | $20.52 | -12.68% |
| Nov 04, 2025 | $32.46 | $31.87 | -1.82% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does Ultragenyx Pharmaceutical (RARE) report earnings?
Ultragenyx Pharmaceutical (RARE) is estimated to report earnings on Nov 03, 2026, After Close (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
What is Ultragenyx Pharmaceutical (RARE) earnings time?
Ultragenyx Pharmaceutical (RARE) earnings time is After Close (Not Confirmed).
What is RARE EPS forecast?
RARE EPS forecast for the fiscal quarter 2026 (Q3) is -1.10.
